Impact of Carrying DNMT3A or TET2 Mutations on Plaque Characteristics and Prognosis in Patients With STEMI Based on OCT
Circulation: Cardiovascular Imaging · 2025
DOI: 10.1161/circimaging.124.017915 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Cardiovascular Imaging, 2025. Verfasst von Qianhui Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang Province, China (Q.S., S.W., M.Z., M.L., C.Z., B.…. Hauptthemen laut MEDLINE: DNA Methyltransferase 3A, Plaque, Atherosclerotic, Mutation, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Clonal hematopoiesis of indeterminate potential is a novel, nontraditional risk factor linked to coronary heart disease. DNMT3A and TET2 are the 2 most prevalent clonal hematopoiesis of indeterminate potential-associated driver genes. This study aims to evaluate their effects on plaque characteristics and prognosis in patients with ST-segment–elevation myocardial infarction. METHODS: Consecutive patients with ST-segment–elevation myocardial infarction (May 2017–May 2019) undergoing routine optical coherence tomography were enrolled. Targeted deep exome sequencing of peripheral blood (custom panel targeting DNMT3A and TET2 ) identified mutations (with a threshold variant allele frequency ≥2%). The primary end point was major adverse cardiovascular events, defined as a composite end point that includes all-cause death, nonfatal myocardial infarction, nonfatal stroke, and revascularization due to clinical ischemic events. RESULTS: Among 628 patients, 12.3% were identified as carriers of DNMT3A or TET2 gene mutations. Patients with DNMT3A/TET2 mutations were older (62.5 versus 55.6 years; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang Province, China (Q.S., S.W., M.Z., M.L., C.Z., B. Yi, S.H., B. Yu, H.J.).
- Key Laboratory of Myocardial Ischemia, Harbin Medical University, Heilongjiang Province, China (Q.S., S.W., M.Z., M.L., C.Z., B. Yi, S.H., B. Yu, H.J.).
ORCID-Profile: Ming Zeng, Chen Zhao, Sining Hu, Bo Yu, Haibo Jia
Zitieren
APA
Sun, Q., Wang, S., Zeng, M., Liu, M., Zhao, C., Yi, B., Hu, S., Yu, B., & Jia, H. (2025). Impact of Carrying DNMT3A or TET2 Mutations on Plaque Characteristics and Prognosis in Patients With STEMI Based on OCT. Circulation: Cardiovascular Imaging. https://doi.org/10.1161/circimaging.124.017915
Vancouver
Sun Q, Wang S, Zeng M, Liu M, Zhao C, Yi B, et al. Impact of Carrying DNMT3A or TET2 Mutations on Plaque Characteristics and Prognosis in Patients With STEMI Based on OCT. Circulation: Cardiovascular Imaging. 2025. doi:10.1161/circimaging.124.017915
BibTeX
@article{Sun2025,
author = {Sun, Qianhui and Wang, Shengfang and Zeng, Ming and Liu, Minghao and Zhao, Chen and Yi, Boling and Hu, Sining and Yu, Bo and Jia, Haibo},
title = {Impact of Carrying DNMT3A or TET2 Mutations on Plaque Characteristics and Prognosis in Patients With STEMI Based on OCT},
journal = {Circulation: Cardiovascular Imaging},
year = {2025},
doi = {10.1161/circimaging.124.017915}
}
EUVIMED